Flurpiridaz Market

Future Market Insights

Flurpiridaz Market

Key Insight

The Flurpiridaz Market is projected to grow from USD 546.9 million in 2025 to USD 1202.6 by 2035, at a CAGR of 8.2%. By Technology type, PET MPI (Positron Emission Tomography Myocardial Perfusion Imaging) will dominate with an 83.9% market share, while Coronary Artery Disease (CAD) will lead the type of application segment with a 43.9% share in 2025.

September 29, 2025

Anurag Sharma

250 Pages

Cite this Report

Flurpiridaz Market

https://www.futuremarketinsights.com/reports/flurpiridaz-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

GE HealthCare
Lantheus Medical Imaging, Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Flurpiridaz Market

Key Players

Similar Industry Reports